Early Adopter Health Organizations, ?Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario' - an OBIO Report
The Ontario Bioscience Innovation Organization (OBIO®) today
released its latest report, ?Achieving Impact Through Adoption of
Innovative Health Technologies: Establishing Early Adopter Health
Organizations as an Accelerator for Economic Growth in Ontario',
which describes an early adopter model to facilitate the evaluation and
adoption of innovative health technologies in Ontario health
organizations.
The report is the result of a series of consultations with
executive-level stakeholders from Ontario health organizations and
industry, as well as representatives from government and other affiliate
organizations.
Following a key recommendation in OBIO's report, ?Tackling the Anchor
Company Challenge ? OBIO Leadership Summit (2017),' which highlighted
the need for early adopter organizations in Ontario, the report provides
a robust model for establishing, governing and supporting these
organizations to best engage with innovators.
The report was launched at the Conference Board of Canada, Council on
Innovation Procurement in Health Care meeting. OBIO CEO, Gail Garland,
was joined by Arden Krystal, President and CEO of the Southlake Regional
Health Centre, Jo-anne Marr, President & CEO of Markham Stouffville
Hospital and Stefano Picone, Director of Finance of Conavi Medical.
"Today, it is clearer than ever that a model to support the early
adoption of novel technologies is crucial if our health science industry
is going to continue to commercialize life-saving products, create jobs
and attract investment in Ontario. We are pleased to present the EAHN
model as a way to achieve these benefits," said Gail Garland, President
and CEO, OBIO.
Overview of the Report:
A network of early adopter health organizations (EAHNs) can facilitate
the evaluation of and access to promising health science innovations
that could benefit human health and wellbeing through their use in the
Ontario healthcare system.
The report presents a governance model for a collaborative ecosystem
wherein industry and health organization end-users can work together
to develop, test, refine, adopt, and deploy novel technologies for the
health sector.
Engagement with an EAHN will allow our growing health sciences
industry to continue to innovate and assess the local market before
they expand their sales to a larger global market. Investments in
Ontario companies will become more attractive due to strong ties with
the local market and foreign companies will be attracted to the
favourable environment for innovation adoption in Ontario.
To read ?Achieving Impact Through Adoption of Innovative Health
Technologies: Establishing Early Adopter Health Organizations as an
Accelerator for Economic Growth in Ontario,' please click
here.
The Ontario Bioscience Innovation Organization (OBIO®) founded
in 2009, is a not-for-profit, membership-based organization engaged in
strategy, programming, policy development and advocacy to further the
commercialization of Ontario's human health technologies positioning
Ontario as a leader in the international marketplace. OBIO advances this
goal through collaborative partnerships with industry, the investment
community, academia, the health system and government.
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada.
A media...
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...